Management of the axilla in T1-2N1 breast cancer

In the setting where the ongoing evolution of management of the axilla in breast cancer is being driven by better understanding of different sub-types of the disease, and of how these respond to chemotherapy, here we discuss management of the axilla in breast cancer patients who present with T1 or T...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Tamer, Mahmoud, Kovacs, Tibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151923/
https://www.ncbi.nlm.nih.gov/pubmed/35637226
http://dx.doi.org/10.1038/s41523-022-00432-y
Descripción
Sumario:In the setting where the ongoing evolution of management of the axilla in breast cancer is being driven by better understanding of different sub-types of the disease, and of how these respond to chemotherapy, here we discuss management of the axilla in breast cancer patients who present with T1 or T2 N1 disease, while making the distinction between triple negative and HER2 positive tumors as one group, and hormone receptor positive/HER2 negative tumors as a second group.

Ejemplares similares